|
|
|
|
394 * !
|
Thu, 8/12/2021,
2:00 PM -
3:50 PM
|
Virtual
|
|
Population Diversity Considerations in Clinical Trials — Invited Papers
|
|
Health Policy Statistics Section, Social Statistics Section, Biopharmaceutical Section, Caucus for Women in Statistics
|
|
Organizer(s): Freda Cooner, Amgen
|
|
Chair(s): Freda Cooner, Amgen
|
|
2:05 PM
|
Digitizing Clinical Trials to Enhance Diversity
Demissie Alemayehu, Pfizer; Kannan Natarajan, Pfizer Inc.; Satrajit Roychoudhury, Pfizer Inc.
|
|
2:25 PM
|
Diversity and Inclusion in Clinical Trials
Rajaa Nahra, AstraZeneca; Claudia Cabrera, AstraZeneca
|
|
2:45 PM
|
Enrollment Disparities by Demographic Subgroups in Oncology Clinical Trials Submitted to the US FDA
Laura Fernandes, FDA
|
|
3:05 PM
|
Leveraging Real-World Evidence to Increase Diversity of Populations in Clinical Trials
Cody Chiuzan, Columbia University
|
|
3:25 PM
|
Discussant: Ruthanna Davi, Medidata Solutions
|
|
3:45 PM
|
Floor Discussion
|
